Methyl Prednisolone Acetate BP 80 mg/2 ml

Business Unit: Human

Medicine Type: Injectable

Generic Name: Methyl Prednisolone Acetate BP 80 mg/2 ml

Therapeutic Class: Glucocorticoids

Indication: Methylprednisolone is a prescription medication used to reduce inflammation. It has immune suppresive effect. Methylprednisolone Acetate is indicated in the treatment of asthma, atopic dermatitis, contact dermatitis, bullous dermatitis herpetiformis, mycosis fungoides, pemphigus, severe erythema multiforme, primary or secondary adrenocortical insufficiency, hypercalcemia associated with cancer, nonsuppurative thyroiditis, ulcerative colitis, hematologic disorders, palliative management of leukemias and lymphomas, sympathetic ophthalmia, keratitis, allergic conjunctivitis, Juvenile rheumatoid arthritis, ankylosing spondylitis, symptomatic sarcoidosis, aspiration pneumonitis.

Dosage & Administration: By intramuscular & intra-articular administration. For intra-articular injection : Rheumatoid and Osteoarthritis: The dose for intra-articular administration depends upon the size of joint and varies with the severity of the condition in the individual patients. Size of joint: Large- 20 to 80 mg, Medium- 10 to 40 mg, Small- 4 to 10 mg Adrenogenital syndrome : A single intramuscular injection of 40 mg every two weeks may be adequate. For maintenance of patients with rheumatoid arthritis, the weekly intramuscular dose will vary from 40 to 120 mg. The usual dosage for patients with dermatologic lesions benefited by systemic corticoid therapy is 40 to 120 mg of methylprednisolone acetate administered intramuscularly at weekly intervals for one to four weeks. In acute severe dermatitis due to poison ivy, relief may result within 8 to 12 hours following intramuscular administration of a single dose of 80 to 120 mg. In chronic contact dermatitis repeated injections at 5 to 0 day intervals may be necessary. In seborrheic dermatitis, a weekly dose of 80 mg may be adequate to control the condition. Following intramuscular administration of 80 to 120 mg asthmatic patients, relief may result within 6 to 48 hours and persist for several days to weeks. Similarly in patients with allergic rhinitis an intramuscular dose of 80 to 120 mg may be followed by relief of coryzal symptoms within six hours persisting for several days to three weeks. Multiple Sclerosis: In treatment of acute exacerbations of multiple sclerosis, daily doses of 160 mg of methylprednisolone for a week followed by 64mg every other day for 1 month have been shown to be effective (4mg of methylprednisolone is equivalent to 5mg of prednisolone). Or, as directed by the registered physician.

Preparation: 2 ml x2 Injection